| Literature DB >> 23514628 |
Alessio Di Luca1, Giuliano Elia, Anne Maria Mullen, Ruth M Hamill.
Abstract
BACKGROUND: Meat quality is a complex trait influenced by a range of factors with post mortem biochemical processes highly influential in defining ultimate quality. High resolution two-dimensional DIfference Gel Electrophoresis (2-D DIGE) and Western blot were applied to study the influence of post mortem meat ageing on the proteome of pork muscle. Exudate collected from the muscle following centrifugation was analysed at three timepoints representing a seven day meat ageing period.Entities:
Year: 2013 PMID: 23514628 PMCID: PMC3639075 DOI: 10.1186/1477-5956-11-9
Source DB: PubMed Journal: Proteome Sci ISSN: 1477-5956 Impact factor: 2.480
Mean (SD) of meat quality traits across three timepoints in the Large White x Landrace/Large White population
| pH | 6.43 (0.20)# | 5.55 (0.13) | - | - | |
| Conductivity | - | 6.50 (3.05) | 10.75 (2.65) | 11.55 (2.44) | 0.10 |
| CIE L* | - | 55.42 (2.01) | 54.80 (2.62) | 54.43 (3.95) | 0.73 |
| CIE a* | - | 7.32 (0.67) | 9.63 (3.71) | 9.34 (2.08) | 0.27 |
| CIE b* | - | 15.43 (0.48)a | 15.53 (0.46)a | 16.74 (1.12)b | |
| Cook Loss (%) | - | 33.49 (3.40)a | 32.42 (2.62)a,b | 29.86 (3.93)b | |
| Drip Loss (%) Day 1-3 | - | - | 3.91 (0.38)@ | - | |
| WBSF (N) | - | 45.67 (3.16)a | 40.31 (5.20)a | 32.01 (3.50)b | |
| Intramuscular fat (%) | - | 0.8 (0.4) | - | - |
L* = lightness; a* = redness; b* = yellowness. Warner-Bratzler shear force (WBSF), Newton (N). Intramuscular fat (IMF) (%). #pH recorded at 45 minutes post mortem. @Drip loss obtained by hanging muscle on day 1 post mortem for 48 hrs according to method of Honikel et al. [25]. Significant values are indicated in italics. Within rows, for day 1 to day 7 comparisons means which do not share a common superscript are significantly different.
Figure 1Four representative 2-D DIGE gel images. Exudate proteins were separated by 2-D DIGE using immobilised pH 4–7 gradients (24 cm, linear) in the first dimension and 12% SDS-PAGE in the second dimension. Figure 1a shows all 136 significantly modulated spots across the three days post mortem (days 1, 3 and 7); the gel image is from an internal standard that consisted of a CyDye3-labelled mixture of the pooled sample. Figure 1b, c and d show representative images from day 1, day 3 and day 7 post mortem respectively; all labelled with CyDye 5. Figure 1b highlights 21 spots, of the 136 significantly changing, that have highest abundance at day 1, whereas Figure 1c and d highlight respectively 3 spots that have a highest abundance at day 3 and 16 spots that have highest abundance at day 7 post mortem.
Figure 2Illustration of the two PCAs carried out using 376 variables (all spots detected) across the three days (●, day 1; ♦, day 3; ▲, day 7). Protein spots are represented by grey numbers. Distinct clustering of the samples by day post mortem is evident from the abundance patterns of these proteins.
Biological function of the identified protein/fragment spots in porcine exudate
| Q08DP0 | Phosphoglucomutase-1 | PGM1 | carbohydrate metabolic process | 2 | 6.4 | 61.6 | f20.16 | |
| Q3ZBZ8 | Stress induced phosphoprotein 1 | STIP1 | immune system process; protein metabolic process; response to stress | 3 | 6 | 62.4 | f30.25 | |
| Q5E9A3 | Poly(rC)-binding protein 1 | PCBP1 | neurological system process; intracellular protein transport; nuclear transport; induction of apoptosis; protein metabolic process; signal transduction | 1 | 6.7 | 37.5 | f10.15 | |
| P20072 | Annexin A7 | ANXA7 | intracellular protein transport; signal transduction; lipid metabolic process; cell motion; signal transduction | 1 | 6.4 | 50 | f10.19 | |
| Q5XLD3 | Creatine kinase M-type | CKM | muscle contraction; metabolic process | 2 | 6.6 | 43.1 | f20.21 | |
| Q8WZ42 | Titin | TTN | assemblage and functioning of vertebrate striated muscles | 2 | 6 | 3816.2 | f20.15 | |
| Q7SIB7 | Phosphoglycerate kinase 1 | PGK1 | carbohydrate metabolic process | 2 | 8 | 44.4 | f20.20 | |
| Q6S4N2 | Heat shock protein 70 | HSPA1B | immune system process; protein metabolic process; response to stress | 20 | 5.6 | 70 | g552 | |
| Q5D862 | Filaggrin-2 | FLG2 | protein metabolic process; cellular component morphogenesis; ectoderm development | 1 | 8.5 | 247.9 | f10.15 | |
| P19378 | Heat shock cognate 71 | HSPA8 | immune system process; protein metabolic process; response to stress | 18 | 5.2 | 70.8 | g290 | |
| P29700 | Alpha-2-HS-glycoprotein (Fragment) | AHSG | immune system process; protein metabolic process; mesoderm development; skeletal system development | 2 | 5.5 | 38.4 | f20.32 | |
| Q29568 | Phosphopyruvate hydratase (Fragment) | FH | glycolysis | 2 | 4.6 | 16.1 | f20.25 | |
| B1A3A0 | Enolase | ENO3 | glycolysis | 2 | 8.1 | 47.1 | f20.23 | |
| P19140 | Alpha-enolase | ENO1 | glycolysis | 2 | 6.4 | 47.2 | f20.17 | |
| Q5XKE0 | Myosin-binding protein C, fast-type | Mybpc2 | muscle contraction; intracellular protein transport; endocytosis; signal transduction; cell adhesion | 2 | 6 | 127.3 | f20.18 | |
| Q0VCY1 | Vesicle-associated membrane protein-associated protein A | VAPA | membrane trafficking regulatory protein | 2 | 8.9 | 27.8 | f20.17 | |
| B1A3A0 | Enolase | ENO3 | glycolysis | 2 | 8.1 | 47.1 | f20.16 | |
| P00571 | Adenylate kinase isoenzyme 1 | AK1 | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 6 | 8.4 | 21.6 | g136 | |
| Q06AB3 | Ubiquitin carboxyl-terminal hydrolase isozyme L3 | UCHL3 | protein metabolic process | 2 | 4.8 | 26.1 | f20.27 | |
| P26234 | Vinculin | VCL | cellular component morphogenesis | 4 | 5.6 | 123.9 | f40.17 | |
| Q2HJ54 | Phosphatidylinositol transfer protein alpha isoform | PITPNA | visual perception; sensory perception; lipid transport; lipid metabolic process | 2 | 6.1 | 31.8 | f20.21 | |
| Q8TCA0 | Leucine-rich repeat-containing protein 20 | LRRC20 | | 2 | 6.1 | 20.5 | f20.28 | |
| P16419 | Myosin-binding protein C, fast-type | Mybpc2 | muscle contraction; intracellular protein transport; endocytosis; signal transduction; cell adhesion; protein metabolic process; cell motion | 2 | 6.2 | 126.7 | f20.19 | |
| Q9TSX9 | Peroxiredoxin-6 | PRDX6 | immune system process; oxygen and reactive oxygen species metabolic process | 15 | 5.7 | 25 | g541 | |
| P34930 | Heat shock 70 kDa protein 1A | HSPA1A | immune system process; protein metabolic process; response to stress | 1 | 5.5 | 70 | f10.15 | |
| A5A8V7 | Heat shock 70 kDa protein 1-like | HSPA1L | immune system process; protein metabolic process; response to stress | 1 | 6 | 70.3 | f10.15 | |
| O97125 | Heat shock protein 68 | Hsp68 | immune system process; protein metabolic process; response to stress | 2 | 5.6 | 69.7 | f20.18 | |
| P48720 | Heat shock 70 kDa protein | HSPA1B | immune system process; protein metabolic process; response to stress | 1 | 5.2 | 70.8 | f10.16 | |
| P19120 | Heat shock cognate 71 | HSPA8 | immune system process; protein metabolic process; response to stress | 1 | 5.4 | 71.1 | f10.16 | |
| Q8T869 | Luminal-binding protein 2 | bip2 | | 1 | 5.1 | 70.4 | f8.17 | |
| P08835 | Serum albumin | ALB | transport | 20 | 6.1 | 69.7 | g504 | |
| Q710C4 | Adenosylhomocysteinase | AHCY | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 13 | 5.9 | 47.7 | g116 | |
| P81605 | Dermcidin | DCD | defense response | 2 | 6.1 | 11.3 | f20.15 | |
| Q3T0P6 | cPhosphoglycerate kinase 1 | PGK1 | carbohydrate metabolic process | 2 | 8.5 | 44.5 | f20.28 | |
| Q08DP0 | Phosphoglucomutase-1 | PGM1 | carbohydrate metabolic process | 19 | 6.4 | 61.6 | g294 | |
| Q9HC38 | Glyoxalase domain-containing protein 4 | GLOD4 | metabolic process | 2 | 5.4 | 34.8 | f20.18 | |
| Q3SX44 | N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 | DDAH2 | mesoderm development; angiogenesis | 2 | 5.7 | 29.8 | f20.15 | |
| P03974 | Transitional endoplasmic reticulum ATPase | VCP | intracellular protein transport; exocytosis; protein metabolic process | 2 | 5.1 | 89.2 | f20.18 | |
| A2THZ2 | Albumin (Fragment) | ALB | transport | 2 | 5.9 | 69.6 | f20.17 | |
| P52552 | Peroxiredoxin-2 (Fragment) | PRDX2 | immune system process; oxygen and reactive oxygen species metabolic process | 7 | 4.7 | 14.2 | g204 | |
| Q0R678 | DJ-1 protein | PARK7 | immune system process; nucleobase, nucleoside, nucleotide and nucleic acid metabolic process; protein metabolic process; response to stress | 5 | 6.4 | 19.9 | f50.21 | |
| Q5E946 | DJ-1 protein | PARK7 | immune system process; nucleobase, nucleoside, nucleotide and nucleic acid metabolic process; protein metabolic process; response to stress | 10 | 6.8 | 20 | g276 | |
| Q1PC32 | Triosephosphate isomerase (Fragment) | TPI | fatty acid biosynthesis; gluconeogenesis; glycolysis | 2 | 6 | 21.8 | f20.19 | |
| Q3ZBZ8 | Stress-induced-phosphoprotein 1 | STIP1 | immune system process; protein metabolic process; response to stress | 2 | 6 | 62.4 | f20.15 | |
| Q1KYT0 | Beta-enolase | ENO3 | glycolysis | 1 | 8.1 | 47 | f10.17 | |
| P34930 | Heat shock 70 kDa protein 1A | HSPA1A | immune system process; protein metabolic process; response to stress | 6 | 5.5 | 70 | f58.25 | |
| P08835 | Serum albumin | ALB | transport | 4 | 5.8 | 66.8 | f40.18 | |
| Q04967 | Heat shock 70 kDa protein 6 | HSPA6 | immune system process; protein metabolic process; response to stress | 1 | 5.8 | 71.1 | f10.19 | |
| Q8WZ42 | Titin | TTN | assemblage and functioning of vertebrate striated muscles | 2 | 6 | 3816.2 | f20.16 | |
| P69678 | Protein CutA | CUTA | cation transport | 2 | 8.6 | 19 | f20.19 | |
| A2THZ2 | Albumin (Fragment) | ALB | transport | 6 | 5.9 | 69.6 | f60.27 | |
| Q29371 | Triosephosphate isomerase | TPI | fatty acid biosynthesis; gluconeogenesis; glycolysis | 11 | 7.2 | 26.6 | g476 |
aSpot numbers refer to Figure 1. bAccession number in the UniProt database. cBiological process of the proteins obtained using PANTHER analysis [27]. dIsoelectric point of the protein. eMolecular weight of the protein. fTurboSEQUEST or gMASCOT score. These data are also available online in the 2-D PAGE reference protein map produced in our previous study under ‘Porcine Database’ [http://proteomics-portal.ucd.ie; Di Luca et al., [26].
Figure 3General classification of biological function (PANTHER) for identified proteins.
ANOVA (p value), fold changes (calculated from the mean normalised volumes between the groups that showed the maximum change) and average normalised spot volumes of the 40 spots characterised by mass spectrometry
| 0.009 | 2.2 | 2.525a | 1.68ab | 1.152b | |
| 1.10E-04 | 2.9 | 0.338a | 0.881b | 0.965b | |
| 7.70E-05 | 2.3 | 2.087a | 1.132b | 0.893b | |
| 0.013 | 2.2 | 0.775a | 0.846a | 1.681b | |
| 0.029 | 2.3 | 0.512a | 0.832ab | 1.163b | |
| 0.004 | 1.9 | 0.599a | 1.115b | 1.126b | |
| 0.032 | 1.4 | 1.585a | 1.135b | 1.144b | |
| 0.03 | 1.3 | 1.485a | 1.193b | 1.111b | |
| 6.96E-04 | 1.6 | 1.732a | 1.065b | 1.066b | |
| 2.44E-04 | 2.7 | 0.215a | 0.581b | 0.47b | |
| 0.009 | 3.4 | 0.649a* | 1.258ab | 2.213b* | |
| 0.005 | 2.8 | 0.752a | 0.809a | 2.078b | |
| 0.045 | 2.1 | 1.386 | 1.106 | 0.666 | |
| 0.002 | 3.4 | 0.733a | 0.607a | 2.049b | |
| 0.021 | 2.7 | 0.716a | 1.802b | 1.954b | |
| 0.047 | 2.5 | 1.525a | 1.028ab | 0.615b | |
| 0.044 | 3.1 | 0.846a | 0.687a | 2.159b | |
| 0.035 | 1.4 | 0.866a | 1.227b | 1.125b# | |
| 0.046 | 1.8 | 0.874a@ | 1.532b@ | 1.112ab | |
| 0.012 | 2.7 | 0.745a | 0.762a | 1.99b | |
| 0.037 | 1.3 | 1.491a | 1.187b | 1.123b | |
| 0.023 | 1.6 | 1.076a | 1.051a | 1.647b | |
| 0.045 | 1.3 | 1.649a | 1.388ab | 1.273b | |
| 0.005 | 1.7 | 1.625a | 1.414a | 0.937b | |
| 0.027 | 2.9 | 1.019a& | 0.971a | 2.836b | |
| 0.004 | 1.7 | 1.579a | 1.313a | 0.927b | |
| 0.031 | 1.3 | 1.048a | 0.866b | 0.818b | |
| 5.30E-05 | 2.2 | 0.789a | 0.901a | 1.697b | |
| 0.036 | 1.4 | 1.46a | 1.076b | 1.114b | |
| 0.007 | 1.5 | 1.419a | 1.312a | 0.956b | |
| 0.009 | 1.4 | 1.462a | 1.299a§ | 1.014b | |
| 0.019 | 1.3 | 1.589a | 1.446ab | 1.196b | |
| 0.027 | 1.3 | 1.562a | 1.387ab | 1.183b | |
| 8.65E-06 | 1.8 | 1.454a | 1.173b | 0.807c | |
| 0.033 | 1.5 | 1.066 | 1.084 | 1.566 | |
| 0.004 | 1.6 | 1.062a | 1.385b | 1.679c | |
| 0.001 | 3.1 | 0.579a | 0.673a | 1.823b | |
| 0.014 | 1.5 | 1.339a | 1.216ab | 0.87b | |
| 0.01 | 1.4 | 1.315a | 1.276a | 0.944b | |
| 0.044 | 1.2 | 1.405a◄ | 1.264ab | 1.138b◄ | |
Within rows, different superscripts indicate significantly different means at the 5% level (following Tukey-Kramer post hoc analysis). * indicates that p value was 0.061. # indicates that p value was 0.053. @ indicates that p value was 0.058. & indicate that p value was 0.056. § indicate that p value was 0.062. ◄ indicate that p value was 0.054. aSpot numbers refer to Figure 1.
Figure 4Differential abundance of the 40 (identified) significantly changing protein spots across days . The spot intensity of each phenotype is represented by the mean of normalised spot intensity on the DIGE gels of four animals for each timepoint. Figures 4A/1 and A/2 show spots that are gradually reducing in abundance across the days post mortem. Figure 4B shows spots that are gradually increasing in abundance across the days post mortem, whereas Figure 4C presents spots whose abundance profile is not linear across the days post mortem. Figure derived from values of Table 3.
Figure 5Western blot analysis of adenylate kinase isoenzyme 1 [AK1 (spot 280)] and vinculin (spot 452). Figure 5 (Western blot) shows representative Western blots of AK1 (spot 280) and vinculin (spot 452). Four biological replicates were profiled at each of three timepoints. Numbers (1 to 4) at the bottom of the image indicate the four animals used in the experiment at each timepoint, each of which was run in an individual gel lane. Three technical replicates were run for each animal and the normalised value was used for statistical analysis. AK1 membranes show a gradual increment of band intensity with time post mortem. Vinculin blots show 4 bands in each lane that are changing across days post mortem. The graph shows the normalised average band density of vinculin for each band across the days post mortem and the average of all four bands normalised across the days post mortem. Band volumes which are significantly different (Tukey-Kramer analysis) are indicated with a and b. Figure 5 (2-D DIGE) shows representative bi- (A) and three- (B) dimensional expression profile of spots 452 (vinculin) and 280 (AK1) across three timepoints post mortem.